English
Home > Products > Meropenem

China Meropenem Factory

Our solutions are broadly acknowledged and dependable by users and may meet consistently developing economic and social requires for Meropenem,CAS NO 96036-03-2,96036-03-2,Meropenem API, We welcome clients, business enterprise associations and mates from all pieces from the earth to make contact with us and request cooperation for mutual advantages.
Meropenem, We welcome an opportunity to do business with you and hope to have pleasure in attaching further details of our products and solutions. Excellent quality, competitive price, punctual delivery and dependable service can be guaranteed. For further inquires please do not hesitate to contact us.

Related Products

Hot Products

  • Emodepside

    Emodepside

    Product Name:Emodepside
    Molecular Formula:C60H90N6O14
    Molecular Weight;1119.39
    CAS Registry Number;155030-63-0
  • Desloratadine

    Desloratadine

    Product Name:Desloratadine
    Molecular Formula:C19H19ClN2
    Molecular Weight;310.82
    CAS Registry Number;100643-71-8
  • L-Alanine benzyl ester 4-toluenesulfonate

    L-Alanine benzyl ester 4-toluenesulfonate

    Product Name:L-Alanine benzyl ester 4-toluenesulfonate
    Molecular Formula:C17H21NO5S
    Molecular Weight:351.42
    CAS Registry Number:42854-62-6
  • Difelikefalin acetate

    Difelikefalin acetate

    Product Name:Difelikefalin acetate
    Molecular Formula:C38H57N7O8
    Molecular Weight;739.90128
    CAS Registry Number;1024829-44-4
  • 1,3-Dibromo-5-chlorobenzene

    1,3-Dibromo-5-chlorobenzene

    Product Name:1,3-Dibromo-5-chlorobenzene
    Molecular Formula:C6H3Br2Cl
    Molecular Weight:270.35
    CAS Registry Number:14862-52-3
  • 2-N-BUTYL-1,3-DIAZA-SPIRO[4,4]NON-1-EN-4-ONE HYDROCHLORIDE

    2-N-BUTYL-1,3-DIAZA-SPIRO[4,4]NON-1-EN-4-ONE HYDROCHLORIDE

    Product Name:2-N-BUTYL-1,3-DIAZA-SPIRO[4,4]NON-1-EN-4-ONE HYDROCHLORIDE
    Molecular Formula:C11H18N2O
    Molecular Weight:194.27
    CAS Registry Number:138402-05-8
  • Related Blog
  • Reviews

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Related Search

Meropenem advance intermediateMeropenem APIMeropenem intermediateMeropenem TrihydrateMeropenem Trihydrate intermediateSide chain for meropenem

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept